Human Longevity, Inc. (HLI) is a genomic-driven health intelligence company that combines DNA sequencing and analysis with machine learning (ML). With a team of research scientists, computing experts, and physicians, HLI developed a database of sequenced genomes and phenotypic (physical traits) data to derive meaningful insights and make discoveries for better personal health plans and new treatment options.
Scope
The report provides information and insights into HLI, including:
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on funding and partnership
- Biography of top management
Reasons to Buy
- Gain insights into HLIs' business operations
- Gain insights into partnership and funding
- Gain understanding about its technology focus
Table of Contents
- Overview
- Technology Focus
- Product Overview
- Partnerships & Funding
- Key Employees
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Edifice Health
- Performance Impact Venture Fund
- Deep Longevity
- NeoGenomics
- SCOR Global Life
- FireFighterAid
- AMRA
- Massachusetts Mutual Life Insurance Co. (MassMutual)
- AstraZeneca
